Skip to main content

Aberdeen Group plc

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1716774 EDINBURGH, X0

Position in XENE

as of Mar 31, 2026 · filed Apr 29, 2026
Position Value
$35,467,371
+$1,839,329 QoQ
Shares Held
609,929
-18.7% QoQ
Ownership
0.631%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in XENE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Aberdeen Group plc holds $1,803,580,461 across 84 Biotechnology names. XENE ranks #16 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XENE

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $35,467,371 609,929
2025-12-31 $33,628,042 750,291
2025-09-30 $23,252,671 579,145
2025-06-30 $16,322,699 521,492
2025-03-31 $13,559,366 404,154
2024-12-31 $11,128,840 283,899
2024-09-30 $9,776,004 248,311
2024-06-30 $8,285,452 212,502
2024-03-31 $1,379,149 32,036
2023-12-31 $1,475,578 32,036